Updates in advanced diffusion-weighted magnetic resonance imaging techniques in the evaluation of prostate cancer.
Diffusion-weighted magnetic resonance imaging (DW-MRI) is considered part of the standard imaging protocol for the evaluation of patients with prostate cancer. It has been proven valuable as a functional tool for qualitative and quantitative analysis of prostate cancer beyond anatomical MRI sequences such as T2-weighted imaging. This review discusses ongoing controversies in DW-MRI acquisition, including the optimal number of b-values to be used for prostate DWI, and summarizes the current literature on the use of advanced DW-MRI techniques. These include intravoxel incoherent motion imaging, which better accounts for the non-mono-exponential behavior of the apparent diffusion coefficient as a function of b-value and the influence of perfusion at low b-values. Another technique is diffusion kurtosis imaging (DKI). Metrics from DKI reflect excess kurtosis of tissues, representing its deviation from Gaussian diffusion behavior. Preliminary results suggest that DKI findings may have more value than findings from conventional DW-MRI for the assessment of prostate cancer.
['Vargas|Hebert Alberto|HA|', 'Lawrence|Edward Malnor|EM|', 'Mazaheri|Yousef|Y|', 'Sala|Evis|E|']
Magnetic resonance imaging Prostate cancer Include intravoxel incoherent motion Diffusion kurtosis imaging Diffusion-weighted imaging